COMIRNATY Rx

Generic Name & Formulations:

COVID-19 vaccine (mRNA); contains 30mcg of nucleoside-modified mRNA encoding the viral spike S glycoprotein of SARS-CoV-2; per 0.3mL; susp for IM inj after dilution; preservative-free.

Company:

Pfizer and BioNTech

Vaccines

Vaccines:

Recent Updates:

Monograph added.

Indications for: COMIRNATY

Active immunization to prevent COVID-19 in individuals ≥16yrs of age.

Adult Dosage:

Give by IM inj only. ≥16yrs: 0.3mL given as a 2-dose series 3 weeks apart.

Children Dosage:

<16yrs: not established.

COMIRNATY Warnings/Precautions:

Have epinephrine inj available. Increased risks of myocarditis and pericarditis (esp. within 7 days after the second dose). Syncope. Immunocompromised. Pregnancy. Nursing mothers.

COMIRNATY Classification:

COVID-19 vaccine.

COMIRNATY Interactions:

Immunosuppressants: may get suboptimal response.

Adverse Reactions:

Inj site reactions (eg, pain, swelling, redness), fatigue, headache, muscle pain, chills, joint pain, fever.

Generic Drug Availability:

How Supplied:

Multiple-dose vials—25, 195 (w. diluent; shipped separately)